Key result
This editorial introduces a collection of 14 articles focusing on the molecular basis, genetic testing, clinical manifestations, outcomes, and management of childhood cardiomyopathies.
Answers are grounded in this paper and cite their sources.
This editorial introduces a collection of 14 articles focused on the genetic basis, clinical manifestations, and management of pediatric cardiomyopathies.
Editorial on the Research Topic Cardiovascular genetics-focus on paediatric cardiomyopathyCardiomyopathies (CMPs) are a large group of disorders characterized by structural, functional, and electrical abnormalities of the heart muscle (1).These conditions are rare in childhood but associated with increased mortality and morbidity (1).Over the last few years, data on the genetic basis, natural history, risk stratification, and treatment of childhood CMPs have emerged.In this Research Topic, experts in the field explored this poorly characterised area with comprehensive and state of the art reviews, original articles, and challenging case reports, dealing with molecular basis, role of genetic testing, clinical manifestations, outcome, and management of childhood CMPs.This Research Topic collected 14 articles, and we are pleased to introduce them to readers of Frontiers in Pediatrics. CardiomyopathiesChildhood CMPs include a large spectrum of diseases, with outcome mainly depending on phenotype, aetiology, and clinical characteristics (2).CMPs are generally categorized into 5 main phenotypes, namely hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic (ACM), and left ventricular non-compaction (LVNC) cardiomyopathy (3).In this regard, Rath et al. provided an overview of childhood CMPs, with a focus on epidemiology, natural history, and outcomes according to clinical phenotype and aetiology.Recently, it has been observed that morphological, functional, and electrical abnormalities of the heart muscle may be part of the spectrum of Marfan syndrome and heritable thoracic aortic disease (4), contributing to morbidity and mortality of these patients.In their review, Laura Muiño-Mosquera et al. reported data on preclinical studies (i.e., mouse models of Marfan syndrome) and described the clinical presentation of cardiovascular involvement of children and adults with genetic aortic diseases. Hypertrophic cardiomyopathyHCM is a myocardial disease characterized by increased left ventricular wall thickness not solely explained by abnormal loading conditions (5).
No takes yet. Share an insight, caveat, or question.
Monda et al. (2023) conducted an editorial in Paediatric cardiomyopathy. This editorial introduces a collection of 14 articles focusing on the molecular basis, genetic testing, clinical manifestations, outcomes, and management of childhood cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: